Re-induction ipilimumab following acquired resistance to combination ipilimumab and anti–PD-1 therapy
Adriana Hepner, Victoria Atkinson, James Larkin, Rebecca A. Burrell, Matteo S. Carlino, Douglas B. Johnson, Lisa Zimmer, Katy K. Tsai, Oliver Klein, Serigne Lo, Andrew Haydon, Prachi Bhave, Megan Lyle, Lalit Pallan, Inês Pires da Silva, Camille L. Gérard, Olivier Michielin, Georgina V. Long, Alexander M. Menzies
Topics & Concepts
IpilimumabMedicineInternal medicineAdverse effectNivolumabImmunotherapyMelanomaCombination therapyCohortOncologySurgeryCancerCancer researchCancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and ManagementMelanoma and MAPK Pathways